Spiral ganglion neurons are protected from degeneration by GDNF gene therapy

Masao Yagi, Sho Kanzaki, Kohei Kawamoto, Brian Shin, Pratik P. Shah, Ella Magal, Jackie Sheng, Yehoash Raphael

Research output: Contribution to journalArticle

118 Citations (Scopus)

Abstract

Perceptual benefits from the cochlear prosthesis are related to the quantity and quality of the patient's auditory nerve population. Multiple neurotrophic factors, such as glial cell line-derived neurotrophic factor (GDNF), have been shown to have important roles in the survival of inner ear auditory neurons, including protection of deafferented spiral ganglion cells (SGCs). In this study, GDNF gene therapy was tested for its ability to enhance survival of SGCs after aminoglycoside/diuretic-induced insult that eliminated the inner hair cells. The GDNF transgene was delivered by adenoviral vectors. Similar vectors with a reporter gene (lacZ) insert served as controls. Four or seven days after bilateral deafening, 5 μl of an adenoviral suspension (Ad-GDNF or Ad-lacZ) or an artificial perilymph was injected into the left scala tympani of guinea pigs. Animals were sacrificed 28 days after deafening and their inner ears prepared for SGC counts. Adenoviral-mediated GDNF transgene expression enhanced SGC survival in the left (viral-treated) deafened ears. This observation suggests that GDNF is one of the survival factors in the inner ear and may help maintain the auditory neurons after insult. Application of GDNF and other survival factors via gene therapy has great potential for inducing survival of auditory neurons following hair cell loss.

Original languageEnglish
Pages (from-to)315-325
Number of pages11
JournalJARO - Journal of the Association for Research in Otolaryngology
Volume1
Issue number4
Publication statusPublished - 2000

Fingerprint

Spiral Ganglion
Glial Cell Line-Derived Neurotrophic Factor
Nerve Degeneration
Genetic Therapy
Inner Ear
Transgenes
Inner Auditory Hair Cells
Survival
Scala Tympani
Perilymph
Neurons
Cochlear Nerve
Cochlear Implants
Alopecia
Nerve Growth Factors
Aminoglycosides
Reporter Genes
Diuretics
Ear
Cell Survival

Keywords

  • Cochlea
  • GDNF
  • Gene transfer
  • Guinea pig
  • Spiral ganglion cell

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Physiology

Cite this

Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. / Yagi, Masao; Kanzaki, Sho; Kawamoto, Kohei; Shin, Brian; Shah, Pratik P.; Magal, Ella; Sheng, Jackie; Raphael, Yehoash.

In: JARO - Journal of the Association for Research in Otolaryngology, Vol. 1, No. 4, 2000, p. 315-325.

Research output: Contribution to journalArticle

Yagi, M, Kanzaki, S, Kawamoto, K, Shin, B, Shah, PP, Magal, E, Sheng, J & Raphael, Y 2000, 'Spiral ganglion neurons are protected from degeneration by GDNF gene therapy', JARO - Journal of the Association for Research in Otolaryngology, vol. 1, no. 4, pp. 315-325.
Yagi, Masao ; Kanzaki, Sho ; Kawamoto, Kohei ; Shin, Brian ; Shah, Pratik P. ; Magal, Ella ; Sheng, Jackie ; Raphael, Yehoash. / Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. In: JARO - Journal of the Association for Research in Otolaryngology. 2000 ; Vol. 1, No. 4. pp. 315-325.
@article{ce2c06184cdc49c6b9273117b97fd0b2,
title = "Spiral ganglion neurons are protected from degeneration by GDNF gene therapy",
abstract = "Perceptual benefits from the cochlear prosthesis are related to the quantity and quality of the patient's auditory nerve population. Multiple neurotrophic factors, such as glial cell line-derived neurotrophic factor (GDNF), have been shown to have important roles in the survival of inner ear auditory neurons, including protection of deafferented spiral ganglion cells (SGCs). In this study, GDNF gene therapy was tested for its ability to enhance survival of SGCs after aminoglycoside/diuretic-induced insult that eliminated the inner hair cells. The GDNF transgene was delivered by adenoviral vectors. Similar vectors with a reporter gene (lacZ) insert served as controls. Four or seven days after bilateral deafening, 5 μl of an adenoviral suspension (Ad-GDNF or Ad-lacZ) or an artificial perilymph was injected into the left scala tympani of guinea pigs. Animals were sacrificed 28 days after deafening and their inner ears prepared for SGC counts. Adenoviral-mediated GDNF transgene expression enhanced SGC survival in the left (viral-treated) deafened ears. This observation suggests that GDNF is one of the survival factors in the inner ear and may help maintain the auditory neurons after insult. Application of GDNF and other survival factors via gene therapy has great potential for inducing survival of auditory neurons following hair cell loss.",
keywords = "Cochlea, GDNF, Gene transfer, Guinea pig, Spiral ganglion cell",
author = "Masao Yagi and Sho Kanzaki and Kohei Kawamoto and Brian Shin and Shah, {Pratik P.} and Ella Magal and Jackie Sheng and Yehoash Raphael",
year = "2000",
language = "English",
volume = "1",
pages = "315--325",
journal = "JARO - Journal of the Association for Research in Otolaryngology",
issn = "1525-3961",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Spiral ganglion neurons are protected from degeneration by GDNF gene therapy

AU - Yagi, Masao

AU - Kanzaki, Sho

AU - Kawamoto, Kohei

AU - Shin, Brian

AU - Shah, Pratik P.

AU - Magal, Ella

AU - Sheng, Jackie

AU - Raphael, Yehoash

PY - 2000

Y1 - 2000

N2 - Perceptual benefits from the cochlear prosthesis are related to the quantity and quality of the patient's auditory nerve population. Multiple neurotrophic factors, such as glial cell line-derived neurotrophic factor (GDNF), have been shown to have important roles in the survival of inner ear auditory neurons, including protection of deafferented spiral ganglion cells (SGCs). In this study, GDNF gene therapy was tested for its ability to enhance survival of SGCs after aminoglycoside/diuretic-induced insult that eliminated the inner hair cells. The GDNF transgene was delivered by adenoviral vectors. Similar vectors with a reporter gene (lacZ) insert served as controls. Four or seven days after bilateral deafening, 5 μl of an adenoviral suspension (Ad-GDNF or Ad-lacZ) or an artificial perilymph was injected into the left scala tympani of guinea pigs. Animals were sacrificed 28 days after deafening and their inner ears prepared for SGC counts. Adenoviral-mediated GDNF transgene expression enhanced SGC survival in the left (viral-treated) deafened ears. This observation suggests that GDNF is one of the survival factors in the inner ear and may help maintain the auditory neurons after insult. Application of GDNF and other survival factors via gene therapy has great potential for inducing survival of auditory neurons following hair cell loss.

AB - Perceptual benefits from the cochlear prosthesis are related to the quantity and quality of the patient's auditory nerve population. Multiple neurotrophic factors, such as glial cell line-derived neurotrophic factor (GDNF), have been shown to have important roles in the survival of inner ear auditory neurons, including protection of deafferented spiral ganglion cells (SGCs). In this study, GDNF gene therapy was tested for its ability to enhance survival of SGCs after aminoglycoside/diuretic-induced insult that eliminated the inner hair cells. The GDNF transgene was delivered by adenoviral vectors. Similar vectors with a reporter gene (lacZ) insert served as controls. Four or seven days after bilateral deafening, 5 μl of an adenoviral suspension (Ad-GDNF or Ad-lacZ) or an artificial perilymph was injected into the left scala tympani of guinea pigs. Animals were sacrificed 28 days after deafening and their inner ears prepared for SGC counts. Adenoviral-mediated GDNF transgene expression enhanced SGC survival in the left (viral-treated) deafened ears. This observation suggests that GDNF is one of the survival factors in the inner ear and may help maintain the auditory neurons after insult. Application of GDNF and other survival factors via gene therapy has great potential for inducing survival of auditory neurons following hair cell loss.

KW - Cochlea

KW - GDNF

KW - Gene transfer

KW - Guinea pig

KW - Spiral ganglion cell

UR - http://www.scopus.com/inward/record.url?scp=0034450210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034450210&partnerID=8YFLogxK

M3 - Article

C2 - 11547811

AN - SCOPUS:0034450210

VL - 1

SP - 315

EP - 325

JO - JARO - Journal of the Association for Research in Otolaryngology

JF - JARO - Journal of the Association for Research in Otolaryngology

SN - 1525-3961

IS - 4

ER -